Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis

NCT00979615 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Rhinitis

Interventions

DRUG: Olopatadine HCL (Patanase) Nasal Spray, 0.6%
DRUG: Azelastine HCl (Astelin) Nasal Spray, 137 mcg

Sponsor

Alcon Research